Cargando…
Hsa_circ_0041150 serves as a novel biomarker for monitoring chemotherapy resistance in small cell lung cancer patients treated with a first-line chemotherapy regimen
PURPOSE: To explore the potential of circRNAs as biomarkers in non-invasive body fluids for monitoring chemotherapy resistance in SCLC patients. METHODS: CircRNAs were screened and characterized using transcriptome sequencing, Sanger sequencing, actinomycin D treatment, and Ribonuclease R assay. Our...
Autores principales: | Zhang, Yang, Chao, Fengmei, Lv, Lihua, Li, Ming, Shen, Zuojun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10620281/ https://www.ncbi.nlm.nih.gov/pubmed/37639013 http://dx.doi.org/10.1007/s00432-023-05317-6 |
Ejemplares similares
-
Serum and Serum Exosomal CircRNAs hsa_circ_0001492, hsa_circ_0001439, and hsa_circ_0000896 as Diagnostic Biomarkers for Lung Adenocarcinoma
por: Kang, Yanli, et al.
Publicado: (2022) -
hsa_circ_0072389, hsa_circ_0072386, hsa_circ_0008621, hsa_circ_0072387, and hsa_circ_0072391 aggravate glioma via miR-338-5p/IKBIP
por: Liang, Jian, et al.
Publicado: (2021) -
Hsa_circ_0028502 and hsa_circ_0076251 are potential novel biomarkers for hepatocellular carcinoma
por: Jiang, Zhenluo, et al.
Publicado: (2019) -
hsa_circ_0006459 and hsa_circ_0015962 affect prognosis of Dengue fever
por: He, JinHua, et al.
Publicado: (2019) -
Plasma Circular RNAs hsa_circ_0001953 and hsa_circ_0009024 as Diagnostic Biomarkers for Active Tuberculosis
por: Huang, Zikun, et al.
Publicado: (2018)